Buyback Spend for Edwards Lifesciences (EW)
Buyback Spend for Edwards Lifesciences (EW): headline value $461.70M · YoY -22.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingBuyback SpendSwitch metric
Latest period
$461.70M
YoY change
-22.9%
5Y CAGR
+7.4%
Peak year (2022)
$1.73B
Latest annual
$893.40M
Buyback Spend history chart for Edwards Lifesciences (EW) from 1999 to 2025
Buyback Spend history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $893.40M | -22.9% | ||
| 2024 | $1.16B | +31.8% | ||
| 2023 | $879.60M | -49.1% | ||
| 2022 | $1.73B | +236.8% | ||
| 2021 | $512.80M | -18.0% | ||
| 2020 | $625.40M | +137.5% | ||
| 2019 | $263.30M | -66.9% | ||
| 2018 | $795.50M | +4.2% | ||
| 2017 | $763.30M | +15.2% | ||
| 2016 | $662.30M | +136.5% | ||
| 2015 | $280.10M | -6.9% | ||
| 2014 | $300.90M | -39.4% | ||
| 2013 | $496.90M | +44.4% | ||
| 2012 | $344.10M | +13.4% | ||
| 2011 | $303.40M | +51.7% | ||
| 2010 | $200.00M | +109.4% | ||
| 2009 | $95.50M | -68.8% | ||
| 2008 | $306.50M | +134.1% | ||
| 2007 | $130.90M | -10.3% | ||
| 2006 | $145.90M | +172.7% | ||
| 2005 | $53.50M | -9.5% | ||
| 2004 | $59.10M | +19.6% | ||
| 2003 | $49.40M | +60.4% | ||
| 2002 | $30.80M | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — |
Buyback Spend values are taken from Edwards Lifesciences's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Edwards Lifesciences (EW) most recent annual buyback spend stands at $893.40M (2025) – declined 22.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Edwards Lifesciences buyback spend compounded at +7.4% per year, with the latest reading among the more recent periods of the dataset.
Edwards Lifesciences buyback spend peaked at $1.73B in 2022; the latest annual figure is $893.40M in 2025 (48.3% below peak).
2022 marks the peak buyback spend at $1.73B, with the historical low of $0 recorded in 1999.
Among 8 Healthcare peers, Edwards Lifesciences (EW) ranks 7th; the peer median for buyback spend is $2.75B.
Edwards Lifesciences Buyback Spend by Year
Edwards Lifesciences Buyback Spend 2025: $893.40M
Edwards Lifesciences buyback spend in 2025 was $893.40M, declined 22.9% below 2024.
Edwards Lifesciences Buyback Spend 2024: $1.16B
Edwards Lifesciences buyback spend in 2024 was $1.16B, surged 31.8% from 2023.
Edwards Lifesciences Buyback Spend 2023: $879.60M
Edwards Lifesciences buyback spend in 2023 was $879.60M, plunged 49.1% below 2022.
Edwards Lifesciences Buyback Spend 2022: $1.73B
Edwards Lifesciences buyback spend in 2022 was $1.73B, surged 236.8% from 2021. This figure represents the highest annual value in the available history.
Edwards Lifesciences Buyback Spend 2021: $512.80M
Edwards Lifesciences buyback spend in 2021 was $512.80M.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Buyback Spend
Companies in the same sector as Edwards Lifesciences, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's buyback spend?
Latest reported buyback spend for Edwards Lifesciences (EW) is $461.70M (period ending December 31, 2025).
How has Edwards Lifesciences buyback spend changed year-over-year?
Edwards Lifesciences (EW) buyback spend changed -22.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences buyback spend?
Edwards Lifesciences (EW) buyback spend compound annual growth rate is +7.4% over the most recent 5 years available.
When did Edwards Lifesciences buyback spend hit its highest annual value?
Edwards Lifesciences buyback spend reached its highest annual value of $1.73B in 2022.
What was Edwards Lifesciences buyback spend in 2024?
Edwards Lifesciences (EW) buyback spend in 2024 was $1.16B.
What was Edwards Lifesciences buyback spend in 2025?
Edwards Lifesciences (EW) buyback spend in 2025 was $893.40M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.